Aerska
Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.
About
Aerska is developing systemically delivered RNA medicines for diseases of the brain. Their approach focuses on precision medicine, utilizing next-generation RNAi and advanced brain shuttle technologies to target the root causes of neurological disorders. The company aims to treat, delay, and prevent these diseases, ultimately preserving minds and enabling healthier, longer lives. Teams look it up for Biotech, Healthcare, Longevity.
Frequently asked
What does Aerska do?
Aerska is a Biotech company that offers Services. Teams look it up for Healthcare, Longevity, Drug Discovery. It is based in Dublin, Ireland and was founded in 2021. Public records show about 23 people and $32M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Aerska raised?
Aerska has raised a total of $32M in funding. The most recent round on record is Unknown.
Where is Aerska headquartered?
Aerska is headquartered in Dublin, Ireland.
When was Aerska founded?
Aerska was founded in 2021.
What industry does Aerska operate in?
Aerska operates in Biotech, Healthcare, Longevity, Drug Discovery, HealthTech.
How many employees does Aerska have?
Aerska has approximately 23 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.